Carbinoxamine (Clistin, Palgic, Rondec, Rhinopront) is a antihistamine and anticholinergic agent. It was first launched in the United States by the McNeil Corporation under the brand name Clistin. It is now available under the brand name Palgic as 4 mg tablets or 4 mg/5 mL liquid. It is approved by the U.S. Food and Drug Administration (FDA) (specifically at the 4 mg dose/strength) for hay fever (a.k.a. allergic rhinitis, SAR and PAR); vasomotor rhinitis; mild urticaria; angioedema, dermatographism and allergic conjunctivitis. Carbinoxamine is a histamine antagonist, specifically an H1-antagonist. The maleic acid salt of the levorotatory isomer is sold as the prescription drug rotoxamine.

CAS：486-16-8
中文别名：2-[(4-氯苯基)(吡啶-2-基)甲氧基]-N,N-二甲基乙胺;氯苯吡醇胺;
英文别名：Carbinoxamina;2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-N,N-dimethylethanamine;Rotoxamine;2-((4-Chlorophenyl)(pyridin-2-yl)methoxy)-N,N-dimethylethanamine;Carbinoxaminum;Clistin;(+/-)-Carbinoxamine;McN-R 73Z;Allergefon;
分子式：C16H19ClN2O
分子量：290.788
精确质量：290.119
Psa：25.36
Logp：3.4026

UNII：982A7M02H5

密度：1.143g/cm3
沸点：381.1ºC at 760mmHg
闪点：184.3ºC

海关编码：2933399090